Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$526K Buy
6,010
+936
+18% +$88.1K 2.64% 14
2020
Q2
$498K Sell
5,074
-1,222
-19% -$108K 2.54% 16
2020
Q1
$480K Sell
6,296
-5,079
-45% -$433K 2.28% 19
2019
Q4
$1.01M Sell
11,375
-1,305
-10% -$108K 1.58% 28
2019
Q3
$960K Buy
+12,680
New +$869K 1.23% 35

Other funds holding ABBV

AMG Funds's ABBV Position: Q3 2020 in Review

AMG Funds increased its AbbVie (ABBV) stake by 18% in Q3 2020, buying an estimated $88.1K and bringing the position to 6,010 shares worth $526K. The position accounts for 2.64% of the portfolio, ranked #14.

AMG Funds first reported a position in ABBV in Q3 2019 and has held it in 5 quarters since. The position peaked at $1.01M in Q4 2019. 2,367 funds tracked by Wall St. Rank hold ABBV as of Q3 2020.

  • AMG Funds held 6,010 shares of AbbVie worth $526K as of Q3 2020.
  • AMG Funds bought 936 AbbVie shares in Q3 2020, an estimated $88.1K.
  • AbbVie made up 2.64% of AMG Funds's portfolio in Q3 2020, its #14 holding.
  • AMG Funds first reported a position in AbbVie in Q3 2019 and has held it in 5 quarters since.
  • AMG Funds's AbbVie position peaked at $1.01M in Q4 2019.
  • 2,367 funds tracked by Wall St. Rank held AbbVie as of Q3 2020.

Based on AMG Funds's 13F filing for Q3 2020, filed 12 Nov 2020.